Hydroquinone, a reactive metabolite of benzene, inhibits NF-κB in primary human CD4+ T lymphocytes

Toxicology and Applied Pharmacology

Volumn 149, Issue 2, 1998, Pages 178-184

  Pyatt, David W ^a   Stillman, Wayne S ^a   Irons, Richard D ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE; CD4 ANTIGEN; CIGARETTE SMOKE; HYDROQUINONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; METABOLITE; T LYMPHOCYTE SUBPOPULATION;

NICOTIANA TABACUM;

EID: 0032054216     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8369     Document Type: Article

References (50)

1. Aoyama K. Effects of benzene inhalation on lymphocyte subpopulations and immune response in mice. Toxicol. Appl. Pharmacol. 85:1986;92-101.
2. Bagasra O., Wright S. D., Seshamma T., Oakes J. W., Pomerantz R. J. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 89:1992;6285-6289.
3. Carotenuto P., Pontesilli O., Cambrier J. C., Hayward A. Desferoxamine blocks IL-2 receptor expression on human T lymphocytes. J. Immunol. 137:1986;2342-2347.
4. Cheung S. C., Nerland D. E., Sonnenfeld G. Inhibition of interferon gamma production by benzene and benzene metabolites. J. Natl. Cancer Inst. 80:1988;1069-1072.
5. Cogswell P. C., Scheinman R. I. Promoter of the human NF-κB p50/p105 gene: Regulation by NF-κB subunits and by c-rel. J. Immunol. 150:1993;2794-2804.
6. Daniele R. P., Dauber J. H., Altose M. D., Rowlands D. T. Jr., Gorenberg D. J. Lymphocyte studies in asymptomatic cigarette smokers. Am. Rev. Respir. Dis. 116:1977;997-1005.
7. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
8. Dinter H., Chiu R., Imagawa M., Karin M., Jones K. A. In vitro. EMBO J. 6:1987;4067-4071.
9. Dornand J., Gerber M. Inhibition of murine T-cell responses by anti-oxidants: The targets of lipo-oxygenase pathway inhibitors. Immunology. 68:1987;384-391.
10. Geiselhart L. A., Christian T., Minnear F., Freed B. M. The cigarette tar componentp. Toxicol. Appl. Pharmacol. 143:1997;30-36.
11. Grimm S., Baeuerle P. A. The inducible transcription factor NF-κB: Structure-function relationship of its protein subunits. Biochem. J. 290:1993;297-308.
12. Haynes W., Krstulovic V., Loomis A. Smoking habit and incidence of respiratory tract infections in a group of adolescent males. Am. Rev. Respir. Dis. 93:1966;730.
13. Henkel T., Baeuerle P. A. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
14. Hoffmann D., Hecht S. S., Wynder E. L. Tumor promoters and cocarcinogens in tobacco carcinogenesis. Environ. Health Perspect. 50:1983;247-257.
15. Holt P. G., Thomas W. R., Keast D. Smoking and immunity. Lancet. 1:1973;1316.
16. Hoyos B., Ballard D., Bohnlein E., Siekevitz M., Greene W. Kappa B-specific DNA binding proteins: Role in the regulation of human interleukin-2 gene expression. Science (Washington, D.C.). 244:1989;457-460.
17. Irons R. D. Quinones as toxic metabolites of benzene. J. Toxicol. Environ. Health. 16:1985;673-678.
18. Irons R. D., Neptun D. A., Pfeifer R. W. Inhibition of lymphocyte transformation and microtubule assembly by quinone metabolites of benzene: Evidence for a common mechanism. J. Reticuloendothel. Soc. 30:1981;359-372.
19. Ivanov V., Merkenschlager M., Ceredig R. Antioxidant treatment of thymic organ cultures decreases NF-κB and TCF-1(a) transcription factor activities and inhibits aB T cell development. J. Immunol. 151:1993;4694-4704.
20. Kaldjian E., McCarthy S. A., Sharrow S. O., Littman D. R., Klausner R. D., Singer A. Nonequivalent effects of PKC activation by PMA on murine CD4 and CD8 cell-surface expression. FASEB J. 2:1988;2801-2806.
21. +. Science (Washington, D.C.). 256:1992;1452-1455.
22. Kronke M., Leonard W. J., Depper J. M., Arya S. K., Gallo R. C., Waldman T. A., Greene W. C. Cyclosporine A inhibits T-cell growth factor gene expression at the level of mRNA transceiption. Proc. Natl. Acad. Sci. USA. 81:1984;5214-5218.
23. Li Q., Geiselhart L., Mittler J. N., Mudzinski S. P., Lawrence D. A., Freed B. M. Inhibition of human T lymphoblast proliferation by hydroquinone. Toxicol. Appl. Pharmacol. 139:1996;317-323.
24. Moore N. C., Girdlestone J., Anderson G., Owen J. J. T., Jenkinson E. J. Stimulation of thymocytes before and after positive selection results in the induction of different NF-kappaB/Rel protein complexes. J. Immunol. 155:1995;4653-4660.
25. Osborn L., Kunkel S., Nabel G. J. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc. Natl. Acad. Sci. USA. 86:1989;2336-2340.
26. Ostrove J. M., Leonard J., Weck K. E., Rabson A. B., Gendelman H. E. Activation of the human immunodeficiency virus by herpes simplex virus type 1. J. Virol. 61:1987;3726-3732.
27. Pfeifer R. W., Irons R. D. Inhibition of lectin-stimulated lymphocyte agglutination and mitogenesis by hydroquinone: Reactivity with intracellular sulfhydryl groups. Exp. Mol. Pathol. 35:1981;189-198.
28. Pfeifer R. W., Irons R. D. Quinones and sulfhydryl-dependent immunotoxicity. Proceedings of the Thirteenth Conference on Environmental Toxicology. 1982a;106-123.
29. Pfeifer R. W., Irons R. D. Effect of benzene metabolites on phytohemagglutinin-stimulated lymphopoiesis in rat bone marrow. J. Reticuloendothel. Soc. 31:1982b;155-170.
30. Pfeifer, R. W. Irons, R. D. 1983, Quinones and sulfhydryl-dependent immunotoxicity, Proceedings of the Thirteenth Conference on Environmental Toxicology, 106, 123, Wright Patterson Air-Force Base, Ohio, AFAML.
31. Pimentel-Muiños F. X., Mazana J., Fresno M. Regulation of interleukin-2 receptor a chain expression and nuclear factor-kB activation by protein kinase C in T lymphocytes. J. Biol. Chem. 269:1994;24424-24429.
32. Post G. B., Snyder R. S., Kalf G. F. Inhibition of mRNA synthesis in rabbit bone marrow nuclei in vitro by quinone metabolites of benzene. Chem.-Biol. Interact. 50:1984;203-211.
33. Post G. B., Snyder R., Kalf G. F. Inhibition of RNA synthesis and interleukin-2 production on lymphocytes in vitro by benzene and its metabolites, hydroquinone andp. Toxicol. Lett. 29:1985;161-167.
34. Rozen M. G., Snyder C. A., Albert R. E. Depressions in B- and T- lymphocyte mitogen-induced blastogenesis in mice exposed to low concentrations of benzene. Toxicol. Lett. 20:1984;343-349.
35. Schmitz M. L. Function and activation of the transcription factor NF-kappaB in the response to toxins and pathogens. Toxicol. Lett. 82-83:1995;407-411.
36. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12:1993;3095-3104.
37. Silverman N. A., Potuin C., Alexander J. C. Jr., Chretien P. B. In vitro lymphocyte reactivity and T cell levels in chronic cigarette smokers. Clin. Exp. Immunol. 22:1975;285-292.
38. Snyder R., Witz G., Goldstein B. D. The toxicology of benzene. Environ. Health Perspect. 100:1993;293-306.
39. Snyder R. S., Kocsis J. J. Current concepts of chronic benzene toxicity. Crit. Rev. Toxicol. June:1975;265-288.
40. Snyder R. S., Longacre S. L., Sammett D., Witmer C. M., Kocsis J. J. Relationship between the toxicity and metabolism of benzene. Advances in Modern Environmental Toxicology Vol. 4. Carcinogenicity and Toxicity of Benzene. 1983;Princeton Scientific Publishers Inc. Princeton. p. 23-36.
41. Sutherland H. J., Lansdorp P. M., Henkelman D. H., Eaves A. C., Eaves C. J. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc. Natl. Acad. Sci. USA. 87:1990;3584-3588.
42. Thanos D., Maniatis T. NF-kappaB: A lesson in family values. Cell. 80:1995;529-532.
43. Thelen M., Wirthmueller U. Phospholipases and protein kinases during phagocyte activation. Curr. Opin. Immunol. 6:1994;106-112.
44. Thomas W. R., Holt P. G., Keast D. Development of alterations in the primary immune response of mice by exposure to fresh cigarette smoke. Int. Arch. Allergy Appl. Immunol. 46:1974;481-486.
45. Wallace L., Pellizzari E., Hartwell T. D., Perritt R., Ziegenfus R. Exposures to benzene and other volatile compounds from active and passive smoking. Arch. Environ. Health. 42:1987;272-279.
46. Wallace L. A. Major sources of benzene exposure. Environ. Health Perspect. 82:1989;165-169.
47. Wallace L. A., Pellizzari E. D. Personal air exposures and breath concentrations of benzene and other volatile hydrocarbons for smokers and nonsmokers. Toxicol. Lett. 35:1986;113-116.
48. Weiss A., Imboden J. B. Cell surface molecules and early events involved in Human T lymphocyte activation. Adv. Immunol. 41:1987;1-31.
49. Wierda D., Irons R. D. Hydroquinone and catechol reduce the frequency of progenitor B lymphocytes in mouse spleen and bone marrow. Immunopharmacology. 4:1982;41-54.
50. Yin S.-N., Li G.-L., Tain F.-D., Fu Z.-I., Jin C., Chen Y.-J., Luo S.-J., Ye P.-Z., Zhang J.-Z., Wang G.-C., Zhang X.-C., Wu H.-N., Zhong Q.-C. A retrospective cohort study of leukemia and other cancers in benzene workers. Environ. Health Perspect. 82:1989;207-213.